ArticleArchives of orthopaedic and trauma surgery2025
Trends, risk factors, and complications of blood transfusion in primary total knee arthroplasty in China: a nationwide retrospective study.
Article in Archives of orthopaedic and trauma surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
introductionIdentifying risk factors and prognosis associated with red blood cell (RBC) transfusions will be meaningful in establishing effective blood management strategies. We aimed to examine the trends, risk factors, and complications of RBC transfusions in primary total knee arthroplasty (TKA) in China. MATERIALS AND
methodsThe Hospital Quality Monitoring System was analyzed for patients undergoing primary TKA between 2013 and 2019. Trends in RBC transfusion rates, mean volume and cost were analyzed. Risk factors for transfusion were identified using multivariable logistic regression. After propensity score matching, the effects of transfusion on complications were examined using logistic regression, with the calculation of odds ratio (OR) and 95% confidence interval (CI).
resultsA total of 11,894 transfused patients and 162,349 non-transfused patients were included. Transfusion rates substantially declined from 20.0% in 2013 to 3.0% in 2019 (P for trend < 0.001), accompanied by a continuous decrease in mean volume (3.9 unit [U] to 2.9 U, P for trend < 0.001) and cost (1,021.8 Chinese Yuan [CNY] to 811.1 CNY, P for trend < 0.001) of transfusion. Risk factors for transfusion included older age (OR 1.37; 95%CI 1.24-1.51), female sex (OR 1.30; 95%CI 1.23-1.35), non-osteoarthritis indication (OR 1.57; 95%CI 1.47-1.69), preoperative anemia (OR 3.76; 95%CI 3.11-4.55), higher Charlson Comorbidity Index score (OR 1.16; 95%CI 0.99-1.36), and hospitals in central (OR 1.47; 95%CI 1.41-1.53) and west (OR 1.41; 95%CI 1.34-1.49) regions. On propensity-adjusted analyses, transfusion was associated with higher risk of 30-day readmission (OR 1.25; 95%CI 1.07-1.47) and deep vein thrombosis (OR 1.49; 95%CI 1.22-1.83), and increased costs (66,845.39 vs. 61,263.56 CNY, P < 0.001).
conclusionsRates, volumes, and costs of RBC transfusion in TKA have fallen substantially in China. However, several risk factors for transfusion should be recognized and appropriately managed, as RBC transfusion increased complication rates and socioeconomic burden.
Indexed as
Identifiers
40116935What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.